New study aims to cut risky pills for seniors with arthritis
NCT ID NCT07278609
First seen Dec 12, 2025 · Last updated Jun 23, 2026 · Updated 27 times
Summary
This study looks at whether a doctor's computer tool (MedSafer) and patient brochures (EMPOWER) can help reduce the use of potentially harmful medications in adults aged 60 and older with rheumatic diseases who take five or more regular drugs. Researchers will follow 100 participants for 18-20 months, comparing medication changes before and after introducing these tools. The goal is to improve medication safety without affecting quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Montreal General Hospital, McGill University Health Centre
RECRUITINGMontreal, Quebec, H3G1A4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MedSafer deprescribing reports and EMPOWER brochures
What this could lead to
If successful, this could provide a simple way to reduce unnecessary or risky medications in older adults with rheumatic conditions, improving safety without harming quality of life.
What could go wrong
This is a small, early-stage observational study, not a large trial. The results may not apply to all patients, and deprescribing might not always be safe or acceptable to doctors or patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.